News | Artificial Intelligence | July 26, 2019

Progenics Pharmaceuticals Collaborating With Veterans Affairs on AI Cancer Imaging Research Program

Collaboration with VA Greater Los Angeles Healthcare System is nation’s first to validate deep learning algorithms in medical imaging of veterans with prostate cancer

Progenics Pharmaceuticals Collaborating With Veterans Affairs on AI Research Program

July 26, 2019 — Oncology company Progenics Pharmaceuticals Inc. announced their collaboration with the Veterans Affairs Greater Los Angeles Healthcare System (VAGLAHS) on Progenics’ artificial intelligence (AI) research program. The collaborative AI research program aims to apply machine learning to medical imaging modalities, enabling standardized, information-driven healthcare practices in prostate cancer. The project is the nation’s first collaborative effort to validate cutting-edge machine learning tools for improving treatment management of veterans with prostate cancer.

Progenics CEO Mark Baker said the company believes that AI can be applied successfully to automate the segmentation, classification and quantification of tumors. Matthew Rettig, M.D., chief of hematology-oncology at VAGLAHS, will be one of the leads on the project.

In the project, the VAGLAHS network will gain access to Progenics’ machine learning platforms, which includes the automated Bone Scan Index (aBSI) and the PSMA-AI platforms. The collaboration would explore novel predictive machine learning algorithms from the digital medical images and its associated clinical outcomes. These novel algorithms would be prospectively validated at VAGLAHS for effective healthcare management of veterans with prostate cancer.

The research collaboration will take every step necessary to protect the veterans’ data. All image and associated clinical data would be anonymized before being processed by the Progenics’ AI platform. Progenics’ AI platform is designed, developed, deployed and maintained according to cybersecurity guidance; NIST cybersecurity framework, the Open Web Application Security Project (OWASP). All data handled by the platform is encrypted in transit and at rest.

For more information: www.progenics.com

Related Content

At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
Researchers reviewed results of prostate biopsies on over 3,400 men who had targets identified on prostate MRI and found that the positive predictive value of the test for prostate cancer was highly variable at different sites
News | Prostate Cancer | July 01, 2020
July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for...
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for
Universal digital operating system for surgery enables health tech companies and start-ups to accelerate, scale and grow

Stefan Vilsmeier, President and CEO of Brainlab Photo courtesy of Brainlab

News | Artificial Intelligence | June 26, 2020
June 26, 2020 — ...
QuEST Global, a global product engineering and lifecycle services company, announced that it has developed a robust artificial intelligence (AI)-powered solution that will enable healthcare professionals to accelerate the screening of COVID-19 patients with pneumonia symptoms.

Getty Images

News | Coronavirus (COVID-19) | June 18, 2020
June 18, 2020 — QuEST Global, a global product engineering and lifecycle services company, announced that it has deve